Ken Arnold is an accomplished medical device executive recognized for leading breakthrough innovations in laser technology and transforming companies through strategic vision and hands-on leadership. As CEO and Co-founder of Precise Light Surgical, he raised $17 million and guided the company from concept to commercialization with a novel tissue-sparing microsurgical platform. His earlier roles at Laserscope and Iridex underscore a consistent track record of scaling innovation into clinical and commercial success, including driving a $715 million acquisition and spearheading next-generation glaucoma treatments. With deep technical expertise, strong investor and clinical relationships, and a relentless focus on patient impact, Ken has built a career defined by precision, performance, and purpose.

Brett Giffin is a dynamic and results-driven healthcare executive known for transforming complex challenges into growth opportunities across diagnostics, medical devices, and healthcare technology sectors. With a deep foundation in commercial strategy, operational execution, and global market expansion, Brett has consistently delivered enterprise value by leading high-performing teams, forging strategic partnerships, and driving innovation in regulated markets. His leadership is grounded in military discipline, entrepreneurial vision, and an unwavering focus on customer outcomes—making him a catalyst for sustainable growth and competitive advantage.

Gordon Matthews is a dynamic entrepreneurial leader with extensive expertise in healthcare supply chain management, operations, and consulting. He specializes in simplifying complex supply chain systems by optimizing human, technological, and process resources to enhance efficiency and execution. With a strong executive presence, he effectively engages C-level stakeholders while fostering collaboration across all levels of an organization. His strategic approach to leveraging technology and streamlining operations has consistently delivered measurable cost savings and improved service delivery across healthcare enterprises.

Dr. David Duffey is a seasoned healthcare executive and physician leader who has dedicated his career to transforming health systems through patient-centered innovation, strategic leadership, and compassionate care. With over three decades of experience guiding clinical and operational excellence, he has led large-scale initiatives that improve outcomes, reduce disparities, and build cultures of trust and accountability. Known for his thoughtful approach to leadership, Dr. Duffey blends deep industry knowledge with a commitment to mentoring and collaboration—making him a powerful force for sustainable change in healthcare and beyond.

Sejal Jonas, PharmD, RPh, is a visionary healthcare executive with over three decades of experience shaping payer strategy, formulary management, and market access for some of the nation’s leading pharmaceutical and healthcare organizations. Known for her deep clinical knowledge, strategic acumen, and commitment to improving health outcomes, Sejal brings a rare ability to bridge the gap between innovation and execution. Her work has empowered brands to thrive in complex regulatory and reimbursement environments, while her leadership continues to influence how healthcare systems deliver value to patients and providers alike.

I’m excited to share my professional biography, which highlights my 40+ years of experience in psychology, executive coaching, and organizational development. As I explore board service opportunities, I look forward to lending my expertise in leadership, team building, and strategic communication to mission-driven organizations.

Laura Freedy is a visionary healthcare executive with more than three decades of experience leading innovation at the intersection of clinical operations, regulatory compliance, and payer-provider collaboration. Known for her integrity, strategic foresight, and commitment to driving meaningful change, Laura has held senior leadership roles across major healthcare organizations, including UnitedHealth Group, Optum, and HTC Global Services. Her ability to align business objectives with clinical and technological solutions has consistently delivered improved health outcomes and operational performance. Passionate about service and mentorship, Laura is now focused on board service where she can share her expertise and guide organizations toward impactful, sustainable growth.

Dr. Michael E. Kuligowski, MD, PhD, MBA, is a globally recognized physician-executive with over four decades of leadership in dermatology, clinical development, and pharmaceutical strategy. With a distinguished career spanning Europe and the United States, he has led the development and approval of numerous dermatologic therapies, including Opzelura® for atopic dermatitis and vitiligo. Known for his scientific rigor, strategic foresight, and collaborative leadership, Dr. Kuligowski continues to influence the future of dermatologic innovation through executive roles, advisory board appointments, and pro-bono consulting in the life sciences sector.

Dr. Larrye Ellis Loss, PharmD, MBA, is a global pharmaceutical executive and consultant with over 40 years of experience leading clinical development, medical affairs, and strategic operations across the life sciences industry. With a distinguished career at AstraZeneca and current advisory work through his own consultancy, Larrye brings deep expertise in drug development, regulatory strategy, and cross-functional leadership. He is known for his integrity, global perspective, and commitment to mentoring the next generation of healthcare professionals. Passionate about service, he also dedicates his time to nonprofit leadership and disaster relief with the American Red Cross.

Lain Anderson is a seasoned leader in healthcare consulting, serving as Managing Director and Co-Head of the Americas Healthcare Sector at L.E.K. Consulting. With nearly two decades of experience advising global biopharma and life sciences companies, he specializes in corporate growth strategy, product commercialization, portfolio prioritization, and investment decision-making. Known for his strategic insight and collaborative approach, Lain helps organizations navigate the intersection of science, market opportunity, and financial performance. His background includes roles at Alnylam Pharmaceuticals and General Electric, along with academic distinction from the Tuck School of Business at Dartmouth and Boston College.

Dr. Andrew King is a distinguished orthopedic surgeon, medical educator, and innovator in pediatric scoliosis treatment, with over 40 years of experience in spinal deformity care, surgical advancements, and medical research. A recognized leader in his field, he has served as Chairman of Orthopedic Surgery at LSU Health Sciences Center and played a pivotal role in shaping pediatric orthopedic education and surgical techniques. His expertise extends beyond clinical practice, as he has consulted for leading medical device companies, contributed to groundbreaking research, and lectured globally on spinal deformities. As G. Dean MacEwen Professor Emeritus, Dr. King continues to bridge the gap between medical innovation and business strategy, seeking to contribute his deep industry knowledge and leadership to organizations dedicated to advancing healthcare and medical technology.

The future of healthcare lies at the intersection of empathy and innovation, where artificial intelligence empowers—not replaces—the human touch. At QurHealth, we’re transforming this vision into reality with Sheela, our AI-driven care platform designed to deliver truly personalized, data-informed support throughout every stage of a patient’s journey. Born from a clinician’s firsthand experience with a fragmented system, Sheela bridges critical gaps in care through real-time insights, intelligent engagement, and culturally sensitive communication. As we scale across health systems and communities, Sheela is proving that AI, when guided by clinical expertise and patient needs, can drive better outcomes, improve equity, and make healthcare more proactive, predictive, and deeply human.

Dr. Anthony J. Marchi, DHSc, is a dynamic healthcare executive and military veteran renowned for leading high-impact transformation across complex systems. With over 30 years of experience in performance improvement, sustainability strategy, and talent development, Dr. Marchi has consistently delivered results in high-pressure environments—from military medical missions to enterprise-level healthcare optimization. His unique blend of clinical insight, operational excellence, and strategic foresight makes him a trusted advisor and leader capable of driving meaningful change in both government and private sector organizations.

After over 40 years of experience in pharmacy, biotech, and medical affairs, I’m excited to share my professional biography that reflects my journey from clinical care to corporate strategy, mentorship, and innovation. Whether supporting startups or collaborating with global medical societies, I’ve always been driven by the desire to connect science with purpose. Here is my biography.

Vidura Stich is a transformational healthcare executive with deep expertise in digital product leadership, organizational design, and enterprise program management. Known for his strategic vision and people-first approach, he has successfully led large-scale transformations across CVS Health, Blue Shield of California, Kaiser Permanente, and Butterfly Network. With a proven ability to build high-performing teams, design scalable structures, and implement digital strategies that drive measurable results, Vidura excels in guiding organizations through complex change while improving service delivery, operational efficiency, and stakeholder engagement.

Mary Hames is a seasoned Medical Affairs executive with a proven track record of leading high-performing teams and delivering strategic impact across rare disease, diagnostics, and oncology. With a foundation in biochemical genetics and over a decade of industry experience, she has played pivotal roles in clinical operations, launch preparedness, and cross-functional leadership. Known for her ability to navigate complex medical landscapes, Mary has successfully built and led medical teams, advanced companion diagnostics, and driven field strategy across multiple therapeutic areas. Her leadership is marked by scientific rigor, operational excellence, and a deep commitment to improving outcomes for patients with rare and life-threatening conditions.